The objective of this project is to develop a nanotechnology platform that can simultaneously be used to diagnose and treat Alzheimer’s. The work will explore how to develop multifunctional nanocarriers that contain both an imaging agent and a therpeutic agent and also will improve the binding capabilities of the nanocarrier allowing regulation of the release of therapeutic molecules to amyloid lesions.